Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2013 1
2014 3
2015 11
2016 4
2018 2
2019 4
2020 3
2021 3
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE–IVUS Investigators. Tsujita K, et al. J Am Coll Cardiol. 2015 Aug 4;66(5):495-507. doi: 10.1016/j.jacc.2015.05.065. J Am Coll Cardiol. 2015. PMID: 26227186 Free article. Clinical Trial.
Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study.
Yamamoto E, Usuku H, Sueta D, Suzuki S, Nakamura T, Matsui K, Matsushita K, Iwasaki T, Sakaino N, Sakanashi T, Hirayama K, Kurokawa H, Kikuta K, Yamamoto N, Sato K, Tokitsu T, Taguchi T, Shiosakai K, Sugimoto K, Tsujita K; ESES-LVH investigators. Yamamoto E, et al. Among authors: tokitsu t. Adv Ther. 2024 Mar;41(3):1284-1303. doi: 10.1007/s12325-024-02780-6. Epub 2024 Feb 4. Adv Ther. 2024. PMID: 38310194 Free PMC article. Clinical Trial.
Incidence, clinical characteristics, and diagnostic approach in transthyretin amyloid cardiomyopathy: The Kumamoto Cardiac Amyloidosis Survey.
Takashio S, Tokitsu T, Matsukawa M, Sakaino N, Fujimoto K, Sakamoto T, Noda K, Tsunoda R, Misumi I, Hirai N, Doi H, Koide S, Mizuno Y, Hirose T, Kurokawa H, Kajiwara I, Ohba K, Miyamoto S, Araki S, Yamamoto E, Matsushita K, Ueda M, Tsujita K; Kumamoto Cardiac Amyloid Survey Investigators. Takashio S, et al. Among authors: tokitsu t. J Cardiol. 2022 Jul;80(1):49-55. doi: 10.1016/j.jjcc.2022.01.002. Epub 2022 Jan 22. J Cardiol. 2022. PMID: 35078683 Free article.
HFA-PEFF scores: prognostic value in heart failure with preserved left ventricular ejection fraction.
Egashira K, Sueta D, Komorita T, Yamamoto E, Usuku H, Tokitsu T, Fujisue K, Nishihara T, Oike F, Takae M, Hanatani S, Takashio S, Ito M, Yamanaga K, Araki S, Soejima H, Kaikita K, Matsushita K, Tsujita K. Egashira K, et al. Among authors: tokitsu t. Korean J Intern Med. 2022 Jan;37(1):96-108. doi: 10.3904/kjim.2021.272. Epub 2021 Dec 21. Korean J Intern Med. 2022. PMID: 34929994 Free PMC article.
Prognostic significance of liver stiffness assessed by fibrosis-4 index in patients with heart failure.
Takae M, Fujisue K, Yamamoto E, Egashira K, Komorita T, Oike F, Nishihara T, Yamamoto M, Hirakawa K, Tabata N, Tokitsu T, Yamanaga K, Sueta D, Hanatani S, Nakamura T, Usuku H, Araki S, Arima Y, Takashio S, Suzuki S, Kaikita K, Matsushita K, Tsujita K. Takae M, et al. Among authors: tokitsu t. ESC Heart Fail. 2021 Oct;8(5):3809-3821. doi: 10.1002/ehf2.13351. Epub 2021 Jun 22. ESC Heart Fail. 2021. PMID: 34156170 Free PMC article.
H2FPEF Score as a Prognostic Value in HFpEF Patients.
Sueta D, Yamamoto E, Nishihara T, Tokitsu T, Fujisue K, Oike F, Takae M, Usuku H, Takashio S, Arima Y, Suzuki S, Nakamura T, Ito M, Kanazawa H, Sakamoto K, Kaikita K, Tsujita K. Sueta D, et al. Among authors: tokitsu t. Am J Hypertens. 2019 Oct 16;32(11):1082-1090. doi: 10.1093/ajh/hpz108. Am J Hypertens. 2019. PMID: 31271191
Clinical significance of plasma galectin-3 in patients with coronary artery disease.
Kusaka H, Yamamoto E, Hirata Y, Fujisue K, Tokitsu T, Sugamura K, Sakamoto K, Tsujita K, Kaikita K, Hokimoto S, Sugiyama S, Ogawa H. Kusaka H, et al. Among authors: tokitsu t. Int J Cardiol. 2015 Dec 15;201:532-4. doi: 10.1016/j.ijcard.2015.08.099. Epub 2015 Aug 10. Int J Cardiol. 2015. PMID: 26322601 No abstract available.
Clinical significance of reactive oxidative metabolites in patients with heart failure with reduced left ventricular ejection fraction.
Nishihara T, Tokitsu T, Sueta D, Oike F, Takae M, Fujisue K, Usuku H, Ito M, Kanazawa H, Araki S, Arima Y, Takashio S, Nakamura T, Sakamoto K, Suzuki S, Kaikita K, Yamamoto E, Tsujita K. Nishihara T, et al. Among authors: tokitsu t. J Card Fail. 2021 Jan;27(1):57-66. doi: 10.1016/j.cardfail.2020.07.020. Epub 2020 Aug 11. J Card Fail. 2021. PMID: 32791184
29 results